In a move to enhance patient care and experience, Metropolis Healthcare Limited, led by Ameera Shah, has introduced the UltraTouch™ Push Button Blood Collection Set (PBBCS) across its nationwide service network. Known as India's second-largest and highly trusted pathology chain, Metropolis aims to make blood collection safer, quicker, and more comfortable for patients of all age groups, including first-time visitors, children, and the elderly.

The UltraTouch™ PBBCS features a cutting-edge design with a thinner needle that minimizes pain during insertion, addressing common patient concerns about blood draws. This innovation aligns with Metropolis' ongoing mission to combine quality and innovation in diagnostics to improve overall healthcare experiences.

Advancing Patient Comfort and Safety

"At Metropolis, we are committed to maintaining the highest standards of quality and innovation in our diagnostic services," said Mr. Surendran Chemmenkotil, Chief Executive Officer, Metropolis Healthcare Limited. "The UltraTouch™ PBBCS represents a significant advancement in patient comfort and safety during blood collection while ensuring the accuracy of our results. By leveraging this technology, we are addressing diagnostic gaps and enhancing the overall patient experience."

Blood tests play a pivotal role in over 70% of medical decisions. However, many patients avoid or delay tests due to fear of discomfort or pain. Studies have shown that nearly 80% of patients believe their blood draw experience heavily influences their satisfaction with healthcare providers.

Clinical Validation of UltraTouch™ PBBCS

A recent study published in the Journal of Evolution of Medical and Dental Sciences (JEMDS) evaluated the UltraTouch™ PBBCS at Metropolis Healthcare's Global Reference Laboratory in Mumbai. The findings highlighted its effectiveness in improving patient comfort and sample reliability. Over 90% of participants reported minimal discomfort, and no signs of hemolysis were observed. Crucial laboratory parameters, such as potassium, iron, and hemoglobin levels, remained consistent, emphasizing the device's reliability and efficacy.

Patient-Centric Innovation

"As someone deeply involved in patient care, I understand the anxiety that often accompanies blood collection," noted Mr. Kannan Alangadan, Chief Operating Officer, Metropolis Healthcare Limited. "At Metropolis, our focus is on elevating the patient experience through innovative technology and compassionate care. Our dedicated team of phlebotomists and technicians ensures exceptional service across our network. With a leading Net Promoter Score of 87, we prioritize patient comfort and satisfaction in every interaction."

Streamlining Laboratory Efficiency

Beyond improving patient comfort, the UltraTouch™ PBBCS enhances laboratory efficiency by reducing blood draw time and minimizing complications. This results in faster turnaround times for test results, ultimately benefiting patients and supporting better healthcare outcomes.

Metropolis Healthcare’s adoption of the UltraTouch™ PBBCS underscores its commitment to advancing diagnostic services and patient satisfaction. With this innovation, the company is setting a new benchmark in pathology services, ensuring that the often-dreaded blood collection process is transformed into a smoother, more patient-friendly experience.